Hummingbird Bioscience
Biotech startup Hummingbird raises extra US$6m in extended Series B funding
SINGAPORE-BASED Hummingbird Bioscience, which is developing antibody drugs for cancer treatment, has raised an additional US$6 million, closing its extended Series B funding round at US$25 million, it...
Hummingbird targets antibody discovery hurdle in fighting cancer
ANTIBODIES is the buzzword in the race to cure cancer. Naturally produced by our immune systems, they can be used as drugs to bind to target proteins and invoke certain effects, such as destroying can...
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More
